Capstone Investment Advisors’s Guardant Health GH Stock Holding History

Capstone Investment Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Buy	+1,691	New	+$184K	﹤0.01%	1534
2026 Q1	–	Sell	-2,239	Closed	-$229K	–	1695
2025 Q4	$229K	Sell	2,239 -35,560	-94%	-$3.18M	﹤0.01%	1463
2025 Q3	$2.36M	Buy	37,799 +22,657	+150%	+$1.23M	﹤0.01%	713
2025 Q2	$788K	Buy	+15,142	New	+$676K	﹤0.01%	938
2024 Q1	–	Sell	-12,468	Closed	-$337K	–	2407
2023 Q4	$337K	Buy	+12,468	New	+$327K	﹤0.01%	1542
2022 Q3	–	Sell	-24,062	Closed	-$971K	–	1701
2022 Q2	$971K	Buy	24,062 +17,057	+243%	+$845K	﹤0.01%	1040
2022 Q1	$464K	Buy	+7,005	New	+$479K	﹤0.01%	1520

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Capstone Investment Advisors's GH Position: Q2 2026 in Review

Capstone Investment Advisors opened a new position in Guardant Health (GH) in Q2 2026: 1,691 shares worth $254K. The stake represents ﹤0.01% of the portfolio and ranks #1534 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in GH as recently as Q4 2025.

Capstone Investment Advisors first reported a position in GH in Q1 2022 and has held it in 7 quarters since. The position peaked at $2.36M in Q3 2025. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Capstone Investment Advisors held 1,691 shares of Guardant Health worth $254K as of Q2 2026.
Guardant Health was a new Capstone Investment Advisors position in Q2 2026.
Guardant Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1534 holding.
Capstone Investment Advisors first reported a position in Guardant Health in Q1 2022 and has held it in 7 quarters since.
Capstone Investment Advisors's Guardant Health position peaked at $2.36M in Q3 2025.
601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.